Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pi-Sunyer X"" wg kryterium: Autor


Tytuł :
Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis.
Autorzy :
Pi-Sunyer X; Columbia University Medical Center, New York, NY, USA.
Apovian CM; Boston University School of Medicine and Department of Medicine Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center, Boston, MA, USA.
McElroy SL; Lindner Center of HOPE, Mason, and Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Dunayevich E; Annexon Biosciences, South San Francisco, CA, USA.
Acevedo LM; Nalpropion Pharmaceuticals, Inc, La Jolla, CA, USA.
Greenway FL; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA. .
Pokaż więcej
Źródło :
International journal of obesity (2005) [Int J Obes (Lond)] 2019 Oct; Vol. 43 (10), pp. 2085-2094. Date of Electronic Publication: 2019 Jan 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Obesity Agents/*adverse effects
Bupropion/*adverse effects
Mood Disorders/*chemically induced
Naltrexone/*adverse effects
Obesity/*drug therapy
Overweight/*drug therapy
Anti-Obesity Agents/therapeutic use ; Bupropion/therapeutic use ; Double-Blind Method ; Drug Combinations ; Humans ; Naltrexone/therapeutic use ; Prospective Studies ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Autorzy :
Pilla SJ; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.
Balasubramanyam A; b Baylor College of Medicine , Houston , TX , USA.
Knowler WC; c National Institute of Diabetes and Digestive and Kidney Diseases , Phoenix , AZ , USA.
Lazo M; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Nathan DM; e Massachusetts General Hospital and Harvard Medical School , Boston , MA , USA.
Pi-Sunyer X; f Columbia University Medical Center , New York , NY , USA.
Clark JM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Maruthur NM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Pokaż więcej
Corporate Authors :
Look AHEAD Research Group
Źródło :
Autoimmunity [Autoimmunity] 2018 Dec; Vol. 51 (8), pp. 408-416. Date of Electronic Publication: 2019 Jan 02.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Autoantibodies/*blood
Diabetes Mellitus, Type 2/*immunology
Islets of Langerhans/*immunology
Overweight/*immunology
Adiposity/immunology ; Aged ; Autoantibodies/immunology ; Autoantigens/immunology ; Autoantigens/metabolism ; Autoimmunity ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/rehabilitation ; Female ; Healthy Lifestyle ; Humans ; Hypoglycemic Agents/therapeutic use ; Islets of Langerhans/metabolism ; Male ; Middle Aged ; Overweight/blood ; Overweight/rehabilitation ; Patient Education as Topic ; Prospective Studies ; Weight Loss/immunology
Czasopismo naukowe
Tytuł :
Lifestyle Interventions Limit Gestational Weight Gain in Women with Overweight or Obesity: LIFE-Moms Prospective Meta-Analysis.
Autorzy :
Peaceman AM; Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Clifton RG; The Biostatistics Center, George Washington University, Washington, DC, USA.
Phelan S; Department of Kinesiology, California Polytechnic State University, San Luis Obispo, California, USA.
Gallagher D; New York Obesity Research Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA.; Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Evans M; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
Redman LM; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Knowler WC; Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA.
Joshipura K; Center for Clinical Research and Health Promotion, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Haire-Joshu D; Center for Diabetes Translation Research, Washington University in St. Louis, St. Louis, Missouri, USA.
Yanovski SZ; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
Couch KA; Phoenix Indian Medical Center, Indian Health Service, Phoenix, Arizona, USA.
Drews KL; The Biostatistics Center, George Washington University, Washington, DC, USA.
Franks PW; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Klein S; Center for Human Nutrition, Washington University in St. Louis, St. Louis, Missouri, USA.
Martin CK; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Pi-Sunyer X; New York Obesity Research Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA.; Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Thom EA; The Biostatistics Center, George Washington University, Washington, DC, USA.
Van Horn L; Department of Preventive Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Wing RR; Department of Psychiatry and Human Behavior, Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA.
Cahill AG; Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri, USA.
Pokaż więcej
Corporate Authors :
LIFE‐Moms Research Group
Źródło :
Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2018 Sep; Vol. 26 (9), pp. 1396-1404. Date of Electronic Publication: 2018 Sep 06.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Life Style*
Gestational Weight Gain/*physiology
Obesity/*physiopathology
Overweight/*physiopathology
Adult ; Diabetes Complications ; Female ; Humans ; Pregnancy ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
Autorzy :
Herman WH; University of Michigan, Ann Arbor, MI .
Pan Q; George Washington University Biostatistics Center, Rockville, MD.
Edelstein SL; George Washington University Biostatistics Center, Rockville, MD.
Mather KJ; Indiana University, Indianapolis, IN.
Perreault L; University of Colorado, Denver, Denver, CO.
Barrett-Connor E; University of California, San Diego, La Jolla, CA.
Dabelea DM; University of Colorado, Denver, Denver, CO.
Horton E; Joslin Diabetes Center, Boston, MA.
Kahn SE; VA Puget Sound Health Care System and University of Washington, Seattle, WA.
Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
Lorenzo C; The University of Texas Health Science Center at San Antonio, San Antonio, TX.
Pi-Sunyer X; Columbia University Medical Center, New York, NY.
Venditti E; University of Pittsburgh, Pittsburgh, PA.
Ye W; University of Michigan, Ann Arbor, MI.
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group
Źródło :
Diabetes care [Diabetes Care] 2017 Dec; Vol. 40 (12), pp. 1668-1677. Date of Electronic Publication: 2017 Oct 11.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Life Style*
Blood Glucose/*metabolism
Glucose Intolerance/*drug therapy
Metformin/*therapeutic use
Obesity/*drug therapy
Overweight/*drug therapy
Adult ; Body Mass Index ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Disease Progression ; Exercise ; Female ; Glucose Intolerance/complications ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Obesity/complications ; Overweight/complications ; Proportional Hazards Models ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.
Autorzy :
Espeland MA; Author affiliations are provided at the end of the article. .
Luchsinger JA; Author affiliations are provided at the end of the article.
Baker LD; Author affiliations are provided at the end of the article.
Neiberg R; Author affiliations are provided at the end of the article.
Kahn SE; Author affiliations are provided at the end of the article.
Arnold SE; Author affiliations are provided at the end of the article.
Wing RR; Author affiliations are provided at the end of the article.
Blackburn GL; Author affiliations are provided at the end of the article.
Bray G; Author affiliations are provided at the end of the article.
Evans M; Author affiliations are provided at the end of the article.
Hazuda HP; Author affiliations are provided at the end of the article.
Jeffery RW; Author affiliations are provided at the end of the article.
Wilson VM; Author affiliations are provided at the end of the article.
Clark JM; Author affiliations are provided at the end of the article.
Coday M; Author affiliations are provided at the end of the article.
Demos-McDermott K; Author affiliations are provided at the end of the article.
Foreyt JP; Author affiliations are provided at the end of the article.
Greenway F; Author affiliations are provided at the end of the article.
Hill JO; Author affiliations are provided at the end of the article.
Horton ES; Author affiliations are provided at the end of the article.
Jakicic JM; Author affiliations are provided at the end of the article.
Johnson KC; Author affiliations are provided at the end of the article.
Knowler WC; Author affiliations are provided at the end of the article.
Lewis CE; Author affiliations are provided at the end of the article.
Nathan DM; Author affiliations are provided at the end of the article.
Peters A; Author affiliations are provided at the end of the article.
Pi-Sunyer X; Author affiliations are provided at the end of the article.
Pownall H; Author affiliations are provided at the end of the article.
Wadden TA; Author affiliations are provided at the end of the article.
Rapp SR; Author affiliations are provided at the end of the article.
Pokaż więcej
Corporate Authors :
Look AHEAD Study Group
Źródło :
Neurology [Neurology] 2017 May 23; Vol. 88 (21), pp. 2026-2035. Date of Electronic Publication: 2017 Apr 26.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Exercise*/psychology
Healthy Lifestyle*
Weight Reduction Programs*
Cognitive Dysfunction/*epidemiology
Overweight/*epidemiology
Overweight/*therapy
Aged ; Aged, 80 and over ; Body Mass Index ; Cognitive Dysfunction/complications ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/psychology ; Diabetes Mellitus, Type 2/therapy ; Female ; Follow-Up Studies ; Humans ; Interviews as Topic ; Male ; Mental Status Schedule ; Middle Aged ; Overweight/psychology ; Patient Education as Topic ; Prevalence ; Self Report ; Social Support ; Time Factors
Czasopismo naukowe
Tytuł :
EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS.
Autorzy :
O'Neil PM
Garvey WT
Gonzalez-Campoy JM
Mora P
Ortiz RV
Guerrero G
Claudius B
Pi-Sunyer X
Pokaż więcej
Corporate Authors :
Satiety and Clinical Adiposity – Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2016 Nov; Vol. 22 (11), pp. 1277-1287. Date of Electronic Publication: 2016 Aug 02.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hispanic Americans*
Outcome Assessment, Health Care*
Hypoglycemic Agents/*pharmacology
Liraglutide/*pharmacology
Overweight/*drug therapy
Weight Loss/*drug effects
Adult ; Comorbidity ; Double-Blind Method ; Female ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Liraglutide/administration & dosage ; Liraglutide/adverse effects ; Male ; Middle Aged ; Obesity/drug therapy ; Obesity/ethnology ; Overweight/ethnology ; Risk Factors
Czasopismo naukowe
Tytuł :
Testosterone and depressive symptoms among men in the Diabetes Prevention Program.
Autorzy :
Kim C; University of Michigan, Ann Arbor, MI, United States. Electronic address: .
Barrett-Connor E; University of California San Diego, La Jolla, CA, United States.
Aroda VR; MedStar Health Research Institute, Hyattsville, MD, United States.
Mather KJ; Indiana University, Indianapolis, IN, United States.
Christophi CA; George Washington University, Rockville, MD, United States.
Horton ES; Joslin Diabetes Center, Boston, MA, United States.
Pi-Sunyer X; Columbia University, New York City, NY, United States.
Bray GA; Louisiana State University, Baton Rouge, LA, United States.
Labrie F; Endoceutics, Quebec, Canada.
Golden SH; Johns Hopkins University, Baltimore, MD, United States.
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group
Źródło :
Psychoneuroendocrinology [Psychoneuroendocrinology] 2016 Oct; Vol. 72, pp. 63-71. Date of Electronic Publication: 2016 Jun 15.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Outcome Assessment, Health Care*
Depression/*metabolism
Glucose Metabolism Disorders/*metabolism
Hypoglycemic Agents/*pharmacology
Overweight/*metabolism
Testosterone/*metabolism
Weight Reduction Programs/*methods
Adult ; Depression/therapy ; Diabetes Mellitus/prevention & control ; Follow-Up Studies ; Glucose Metabolism Disorders/therapy ; Humans ; Hypoglycemic Agents/administration & dosage ; Male ; Metformin/administration & dosage ; Metformin/pharmacology ; Middle Aged ; Overweight/therapy
Czasopismo naukowe
Tytuł :
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.
Autorzy :
Pi-Sunyer X; a Division of Endocrinology , Columbia University Medical Center , New York , NY , USA.
Shanahan W; b Formerly of the division of Preclinical and Clinical Drug Development , Arena Pharmaceuticals, Inc ., San Diego , CA , USA.
Fain R; c Formerly of the Global Neuroscience Business Unit, Eisai Inc ., Woodcliff Lake , NJ , USA.
Ma T; c Formerly of the Global Neuroscience Business Unit, Eisai Inc ., Woodcliff Lake , NJ , USA.
Garvey WT; d Department of Nutrition Sciences , University of Alabama at Birmingham, and the Birmingham VA Medical Center , Birmingham , AL , USA.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2016 Aug; Vol. 128 (6), pp. 591-7. Date of Electronic Publication: 2016 Jul 18.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Benzazepines/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Overweight/*drug therapy
Serotonin Receptor Agonists/*therapeutic use
Adolescent ; Adult ; Aged ; Blood Glucose ; Body Mass Index ; Continental Population Groups ; Counseling ; Diet ; Double-Blind Method ; Exercise ; Female ; Glycated Hemoglobin A ; Humans ; Life Style ; Male ; Middle Aged ; Obesity/therapy ; Overweight/therapy ; Weight Loss/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.
Autorzy :
Ard J; Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Cannon A; Endocrine Metabolic Associates, Philadelphia, PA, USA.
Lewis CE; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Lofton H; New York University School of Medicine, New York, NY, USA.
Vang Skjøth T; Novo Nordisk A/S, Søborg, Denmark.
Stevenin B; Novo Nordisk Inc, Plainsboro, NJ, USA.
Pi-Sunyer X; Columbia University, New York, NY, USA.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2016 Apr; Vol. 18 (4), pp. 430-5. Date of Electronic Publication: 2016 Feb 11.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Obesity Agents/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Liraglutide/*therapeutic use
Obesity/*drug therapy
Overweight/*drug therapy
Prediabetic State/*drug therapy
Adult ; African Continental Ancestry Group ; Anti-Obesity Agents/administration & dosage ; Anti-Obesity Agents/adverse effects ; Asian Continental Ancestry Group ; Body Mass Index ; Combined Modality Therapy/adverse effects ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/ethnology ; Diet, Reducing/ethnology ; Double-Blind Method ; European Continental Ancestry Group ; Exercise ; Female ; Glycated Hemoglobin A/analysis ; Humans ; Hyperglycemia/ethnology ; Hyperglycemia/prevention & control ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Liraglutide/administration & dosage ; Liraglutide/adverse effects ; Male ; Obesity/complications ; Obesity/ethnology ; Obesity/therapy ; Overweight/complications ; Overweight/ethnology ; Overweight/therapy ; Prediabetic State/blood ; Prediabetic State/complications ; Prediabetic State/ethnology ; Quality of Life ; Weight Loss/drug effects ; Weight Loss/ethnology
Czasopismo naukowe
Tytuł :
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
Autorzy :
Kim C; Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
Christophi CA; Biostatistics Center, George Washington University, Rockville, MD, USA.
Goldberg RB; Department of Medicine, University of Miami, Miami, FL, USA.
Perreault L; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Dabelea D; Department of Preventive Medicine and Biometrics, Colorado School of Public Health, Aurora, CO, USA.
Marcovina SM; Department of Medicine, University of Washington, Seattle, WA, USA.
Pi-Sunyer X; Division of Endocrinology, Columbia University Medical Center, New York City, NY, USA.
Barrett-Connor E; Department of Family and Preventive Medicine, University of California, San Diego, CA, USA.
Pokaż więcej
Źródło :
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2016 Jan; Vol. 33 (1), pp. 32-8. Date of Electronic Publication: 2015 May 29.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adiponectin/*blood
C-Reactive Protein/*analysis
Diabetes Mellitus, Type 2/*etiology
Diabetes, Gestational/*physiopathology
Glucose Intolerance/*blood
Overweight/*therapy
Tissue Plasminogen Activator/*blood
Adult ; Biomarkers/blood ; Body Mass Index ; Cohort Studies ; Combined Modality Therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/prevention & control ; Diet, Reducing ; Female ; Fibrinogen/analysis ; Glucose Intolerance/complications ; Glucose Intolerance/etiology ; Glucose Intolerance/therapy ; Humans ; Hypoglycemic Agents/therapeutic use ; Life Style ; Middle Aged ; Motor Activity ; Overweight/complications ; Pregnancy ; Risk ; United States/epidemiology ; Weight Loss
Czasopismo naukowe
Tytuł :
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.
Autorzy :
Espeland MA; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC .
Glick HA; Weight and Eating Disorder Program, University of Pennsylvania, Philadelphia, PA.
Bertoni A; Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
Brancati FL; Johns Hopkins School of Medicine, Baltimore, MD.
Bray GA; Pennington Biomedical Research Center, Baton Rouge, LA.
Clark JM; Johns Hopkins School of Medicine, Baltimore, MD.
Curtis JM; Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Shiprock, NM.
Egan C; Weight Control and Diabetes Research Center, Brown Medical School/The Miriam Hospital, Providence, RI.
Evans M; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Foreyt JP; Department of Medicine, Baylor College of Medicine, Houston, TX.
Ghazarian S; Roybal Comprehensive Health Center, Los Angeles, CA.
Gregg EW; Centers for Disease Control and Prevention, Atlanta, GA.
Hazuda HP; University of Texas Health Science Center at San Antonio, San Antonio, TX.
Hill JO; Anschutz Health and Wellness Center, University of Colorado Health Sciences Center, Aurora, CO.
Hire D; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Horton ES; Department of Clinical Epidemiology, Joslin Diabetes Center, Boston, MA.
Hubbard VS; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Jakicic JM; Diabetes Unit, Department of Health and Physical Activity, University of Pittsburgh, Pittsburgh, PA.
Jeffery RW; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN.
Johnson KC; Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, TN.
Kahn SE; Department of Medicine, University of Washington, Seattle, WA.
Killean T; Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Shiprock, NM.
Kitabchi AE; Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, TN.
Knowler WC; Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ Southwest American Indian Center, National Institute of Diabetes and Digestive and Kidney Diseases, Shiprock, NM.
Kriska A; Diabetes Unit, Department of Health and Physical Activity, University of Pittsburgh, Pittsburgh, PA.
Lewis CE; Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
Miller M; Anschutz Health and Wellness Center, University of Colorado Health Sciences Center, Aurora, CO.
Montez MG; University of Texas Health Science Center at San Antonio, San Antonio, TX.
Murillo A; Department of Medicine, University of Washington, Seattle, WA.
Nathan DM; Massachusetts General Hospital, Boston, MA.
Nyenwe E; Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, TN.
Patricio J; Division of and Department of Medicine, St. Luke's-Roosevelt Hospital, New York, NY.
Peters AL; Roybal Comprehensive Health Center, Los Angeles, CA.
Pi-Sunyer X; Division of and Department of Medicine, St. Luke's-Roosevelt Hospital, New York, NY.
Pownall H; Department of Medicine, Baylor College of Medicine, Houston, TX.
Redmon JB; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN.
Rushing J; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Ryan DH; Pennington Biomedical Research Center, Baton Rouge, LA.
Safford M; Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL.
Tsai AG; Division of Internal Medicine, University of Colorado Health Sciences Center, Aurora, CO.
Wadden TA; Weight and Eating Disorder Program, University of Pennsylvania, Philadelphia, PA.
Wing RR; Weight Control and Diabetes Research Center, Brown Medical School/The Miriam Hospital, Providence, RI.
Yanovski SZ; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Zhang P; Centers for Disease Control and Prevention, Atlanta, GA.
Pokaż więcej
Corporate Authors :
Look AHEAD Research Group
Źródło :
Diabetes care [Diabetes Care] 2014 Sep; Vol. 37 (9), pp. 2548-56.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Care Costs*
Life Style*
Cardiovascular Diseases/*economics
Diabetes Mellitus, Type 2/*economics
Health Services/*economics
Obesity/*economics
Overweight/*economics
Adult ; Aged ; Cardiovascular Diseases/etiology ; Diabetes Mellitus, Type 2/etiology ; Diabetes Mellitus, Type 2/therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Obesity/complications ; Overweight/complications ; Single-Blind Method
Czasopismo naukowe
Tytuł :
Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.
Autorzy :
Kim C; University of Michigan, Ann Arbor, Michigan 48109-2800, USA. />Pi-Sunyer X
Barrett-Connor E
Stentz FB
Murphy MB
Kong S
Nan B
Kitabchi AE
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2013 Jul; Vol. 98 (7), pp. 3049-57. Date of Electronic Publication: 2013 May 24.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Diet, Reducing*
Exercise*
Diabetes Mellitus/*prevention & control
Glucose Intolerance/*therapy
Overweight/*therapy
Sex Hormone-Binding Globulin/*analysis
Adult ; African Americans ; Body Mass Index ; Combined Modality Therapy ; Diabetes Mellitus/ethnology ; Diabetes Mellitus/etiology ; Estradiol/blood ; European Continental Ancestry Group ; Female ; Follow-Up Studies ; Glucose Intolerance/blood ; Glucose Intolerance/ethnology ; Glucose Intolerance/physiopathology ; Hispanic Americans ; Humans ; Hypoglycemic Agents/therapeutic use ; Metformin/therapeutic use ; Middle Aged ; Overweight/blood ; Overweight/ethnology ; Overweight/physiopathology ; Premenopause ; Testosterone Congeners/blood ; United States
Czasopismo naukowe
Tytuł :
The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus.
Autorzy :
Rice TB; University of Pittsburgh, Pittsburgh, PA, USA. />Foster GD
Sanders MH
Unruh M
Reboussin D
Kuna ST
Millman R
Zammit G
Wing RR
Wadden TA
Kelley D
Pi-Sunyer X
Newman AB
Pokaż więcej
Corporate Authors :
Sleep AHEAD Research Group
Źródło :
Sleep [Sleep] 2012 Sep 01; Vol. 35 (9), pp. 1293-8. Date of Electronic Publication: 2012 Sep 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Self Report*
Coronary Disease/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Overweight/*epidemiology
Sleep Apnea, Obstructive/*epidemiology
Stroke/*epidemiology
Comorbidity ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Obesity/epidemiology ; Odds Ratio ; Polysomnography/methods ; Prevalence ; Risk Factors
Czasopismo naukowe
Tytuł :
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
Autorzy :
Van Gaal L; Department of Diabetology, Metabolism, and Clinical Nutrition, University Hospital Antwerp, Antwerp, Belgium. />Pi-Sunyer X
Després JP
McCarthy C
Scheen A
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2008 Feb; Vol. 31 Suppl 2, pp. S229-40.
Typ publikacji :
Journal Article
MeSH Terms :
Diet, Reducing*
Cardiovascular Diseases/*prevention & control
Heart Diseases/*prevention & control
Metabolic Diseases/*prevention & control
Obesity/*complications
Overweight/*complications
Piperidines/*therapeutic use
Pyrazoles/*therapeutic use
Cannabinoid Receptor Antagonists ; Cannabinoids/antagonists & inhibitors ; Cardiovascular Diseases/epidemiology ; Clinical Trials, Phase III as Topic ; Exercise ; Heart Diseases/epidemiology ; Humans ; Metabolic Diseases/epidemiology ; Rimonabant ; Risk Factors ; Safety
Czasopismo naukowe
Tytuł :
[Rimonabant improves cardiometabolic risk profile in obese or overweight subjects: overview of RIO studies].
Autorzy :
Scheen AJ; Université de Liège, Service de diabétologie, nutrition et maladies métaboliques, CHU Sart Tilman, Liège, Belgique. />Van Gaal LG
Després JP
Pi-Sunyer X
Golay A
Hanotin C
Pokaż więcej
Transliterated Title :
Le rimonabant améliore le profit de risque cardio-métabolique chez le sujet obèse ou en surpoids: synthèse des etudes "RIO".
Źródło :
Revue medicale suisse [Rev Med Suisse] 2006 Aug 23; Vol. 2 (76), pp. 1916-23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Obesity Agents/*therapeutic use
Metabolic Syndrome/*prevention & control
Obesity/*drug therapy
Overweight/*drug effects
Piperidines/*therapeutic use
Pyrazoles/*therapeutic use
Cannabinoid Receptor Antagonists ; Humans ; Randomized Controlled Trials as Topic ; Rimonabant
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies